Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 07/28/2026 | Verkauf | 235.18 | 1,600 | 376,288 | Form 4 |
| DGX | Kuppusamy Karthik | SVP, Clinical Solutions | 07/22/2026 | L | 206.81 | 37 | 7,652 | Form 4 |
| DGX | Carter Robert B | Director | 07/22/2026 | L | 206.80 | 11 | 2,275 | Form 4 |
| DGX | Gregg Vicky B | Director | 07/22/2026 | Zuteilung | 206.81 | 72 | 14,890 | Form 4 |
| DGX | Plewman Patrick | SVP for Diagnostic Services | 07/22/2026 | L | 206.81 | 46 | 9,513 | Form 4 |
| DGX | Main Timothy L | Director | 07/22/2026 | L | 206.81 | 21 | 4,343 | Form 4 |
| DGX | Samad Sam | Executive Vice President & CFO | 07/22/2026 | Zuteilung | 206.81 | 102 | 21,094 | Form 4 |
| DGX | Lassiter Wright III | Director | 07/22/2026 | L | 206.81 | 6 | 1,241 | Form 4 |
| DGX | Delaney Mark E | SVP & Chief Commercial Officer | 07/22/2026 | L | 206.81 | 34 | 7,031 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).